Cochrane Abstracts
Rufinamide add‐on therapy for drug‐resistant epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rufinamide Add‐on Therapy for Drug‐resistant Epilepsy." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434218/all/Rufinamide_add‐on_therapy_for_drug‐resistant_epilepsy.
Rufinamide add‐on therapy for drug‐resistant epilepsy. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434218/all/Rufinamide_add‐on_therapy_for_drug‐resistant_epilepsy. Accessed November 22, 2024.
Rufinamide add‐on therapy for drug‐resistant epilepsy. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434218/all/Rufinamide_add‐on_therapy_for_drug‐resistant_epilepsy
Rufinamide Add‐on Therapy for Drug‐resistant Epilepsy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434218/all/Rufinamide_add‐on_therapy_for_drug‐resistant_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rufinamide add‐on therapy for drug‐resistant epilepsy
ID - 434218
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434218/all/Rufinamide_add‐on_therapy_for_drug‐resistant_epilepsy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
